Switch to:

CRISPR Therapeutics AG Accounts Receivable

: $0.11 Mil (As of Sep. 2020)
View and export this data going back to 2016. Start your Free Trial

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. CRISPR Therapeutics AG's accounts receivables for the quarter that ended in Sep. 2020 was $0.11 Mil.

Accounts receivable can be measured by Days Sales Outstanding. CRISPR Therapeutics AG's Days Sales Outstanding for the quarter that ended in Sep. 2020 was 67.82.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. CRISPR Therapeutics AG's Net-Net Working Capital per share for the quarter that ended in Sep. 2020 was $17.34.


CRISPR Therapeutics AG Accounts Receivable Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

CRISPR Therapeutics AG Annual Data
Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Accounts Receivable Premium Member Only 0.34 3.16 2.63 0.09 0.10

CRISPR Therapeutics AG Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Accounts Receivable Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.10 25.12 0.03 0.11

CRISPR Therapeutics AG Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


CRISPR Therapeutics AG Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

CRISPR Therapeutics AG's Days Sales Outstanding for the quarter that ended in Sep. 2020 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.11/0.148*91
=67.82

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), CRISPR Therapeutics AG's accounts receivable are only considered to be worth 75% of book value:

CRISPR Therapeutics AG's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2020 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(1365.99+0.75 * 0.11+0.5 * 0-141.717
-0-0)/70.6039
=17.34

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


CRISPR Therapeutics AG Accounts Receivable Related Terms


CRISPR Therapeutics AG Accounts Receivable Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)